Latest News & Analysis
stocks
2 companies poised to capitalize on the rise of GLP-1 drugs
Why Pfizer and Roche look like top choices for investors in the war to tip the scales.
stocks
Does this bank have what it takes to compete with the big 4?
Organic growth and a recent acquisition were the focus of their investor day.
personal-finance
Future Focus: The best Christmas gift for an investor
Give yourself the best gift - use the time to get 2026 off on the right foot.
funds
Should investors access private equity through semiliquid funds?
An opportunity to access innovation.
etfs
A Bitcoin ETF doubled in value. Its investors made only one-fourth of that
iShares Bitcoin Trust ETF gained over 46% per year since inception, but the average dollar made only 11% annually.
personal-finance
9 winning investment strategies
There are many ways to invest in stocks, but some strategies are more effective than others.
stocks
Looking for growth outside the ASX100
Small caps have outperformed blue chips this year. Here’s some opportunities outside the ASX100.
stocks
Netflix and Warner Bros. Discovery: Surprisingly high merger price alters shareholder value for both
Our view on the blockbuster merger.
personal-finance
Transitioning to a ‘grown up’ portfolio
What do you do when you have made investments in the past that you no longer believe in?
stocks
The trillion-dollar club: Are these mega-sized stocks still buys?
The biggest stocks got bigger this year, breaking multi-trillion-dollar milestones.
stocks
New pricing model for embattled ASX tech leader
Investor day shows off potentially disruptive pricing model.
investing
Invest like you are bad at making predictions
A lesson in dialing down overconfidence and diversifying.
markets
Market Minute: Inflation pressures remain high
The U.S. Fed’s meeting looms, while inflation remains elevated in Australia
personal-finance
Unconventional wisdom: Troubling environment for returns predicted
Are lower returns a mathematical certainty?
of 641
Viewing 1 to 16 of 10243